Company intelligence / Profile preview

Strategy Advisors

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Insight Strategy Advisors (ISA) was a premier management consulting firm dedicated to the life sciences industry, providing commercial development strategy, market research, and product lifecycle management services. The firm specialized in helping pharmaceutical and biotechnology companies navigate complex market access, pricing, and reimbursement landscapes. ISA was recognized for its deep expertise in oncology, rare diseases, and specialty therapeutics, offering data-driven insights to optimize product launches and commercial success. In 2018, the company was acquired by Precision Medicine Group and integrated into its Precision Value & Health division, where its capabilities continue to support global biopharmaceutical clients.

Industry: Consulting

Partnerships

Precision Medicine GroupPrecision Value & Health

Beyond the preview

Go deeper on Strategy Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Strategy Advisors.

Explore the full profile